Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
World Cancer Day
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Search within results
Search within results
Filter
Filter
Refine by Access
All
Content accessible to Me
Refine by Date
From
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
—
To
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Submit
Print
Save
Email this link
Share Link
Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:
https://jnccn.org/browse?access=all&page=6&pageSize=10&sort=datedescending
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Browse
You are looking at
51
-
60
of
3,806
items for
Refine by Access: All
x
Clear All
Items per page
10
20
50
Sort by
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page:
1
2
3
4
5
6
7
8
9
10
11
...
Full access
BPI22-024: Assessing the Adherence to Standard of Care With Durvalumab and Overcoming Barriers in the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: A Single Institution Retrospective Study
Madhulika Urella, Jai Kumar Khatri, Anwar Khurram, Vivek Yadala, Adarsh Sidda, Noman Jang Khan, and Maria Tria Tirona
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
BPI22-025: The Timing of Screening Breast MRI and Mammography for Women With Genetic Predisposition for Cancer
Xia Wang, Maxine D. Chang, Marie Catherine Lee, and Bethany L. Niell
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CGE22-095: CCND1 Amplification in Pancreatic Ductal and Ampullary Adenocarcinoma and Its Impact on Patients’ Survival: A Single Centre Observational Study
Shuchismita Chakraborty and Shibajyoti Ghosh
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CGE22-096: Trends in The Use of Comprehensive Genomic Profiling Among Older Patients With Advanced Cancer From 2018 to 2020 in the United States: Findings From the SEQUENCE Study
Monica Chase, Yihua Xu, Eleanor O Caplan, Nicole Myer, Sheetal Sheth, Brandon T Suehs, and Gboyega Adeboyeje
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CGE22-097: Mapping the Mutational Landscape in Patients With Advanced Malignancies Enrolled to Early Phase Clinical Trials
Farasat Kazmi, Kaiser Anam, Thomas Foord,, Andrew Blake, Simon Lord, Mark Middleton, Debashis Sarker, and Sarah P Blagden
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CGE22-098: Correlation Between Trough Level of Abiraterone Acetate and PSA Response in Metastatic Hormone Sensitive Prostate Cancer
Zin Myint, Jill Kolesar, Joseph R McCorkle, Jianrong Wu, Carleton S Ellis, Danielle E Otto, and Peng Wang
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CGE22-100: Community Oncologists’ Current and Future Patterns of Germline Testing for Patients With Early-Stage Breast Cancer
Dewilka Simons, Yolaine Jeune-Smith, Bruce Feinberg, Stephanie Fortier, and Ajeet Gajra
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CGE22-101: Dynamically Accumulating Homologous Recombination Deficiency (HRD) Status Served as an Important Prognosis Factor in High-Grade Serous Ovarian Cancer
Rongjia Su,, Yuan Liu, Xiaomei Wu, Jiangdong Xiang,, and Xiaowei Xi
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CGE22-102: Characterization of Genomic Alteration of FGFR-3 by Integrating Analysis The Cancer Genome Atlas
Quoc Thang Pham, Hieu Trong Le, Tuan Dung Vu, Thao Quyen Nguyen, Thanh Tu Nguyen, Thi Thanh Tam Bui, Thanh Tu Duong, Dang Anh Thu Phan, and Quoc Dat Ngo
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CGE22-103: Identifying Patients at Risk for Hereditary Myeloid Malignancy Syndromes Using a Self-Administered Questionnaire as an Initial Screening Tool: A Single Center Experience
Mohammad Faizan Zahid, Courtney Dryden, Ruth Ikpefan, Kelsey Moriarty, Robert H Collins, Madhuri Vusirikala, Yazan F Madanat, and Prapti A Patel
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Items per page
10
20
50
Sort by
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page:
1
2
3
4
5
6
7
8
9
10
11
...
[100.24.115.215]
100.24.115.215
